Request for Proposals: HepConnect Initiative to Expand Harm Reduction & Community Education

Jun 25, 2019 | Kim Rodgers

Harm Reduction Coalition released a request for proposals for the Support Harm Reduction & Community Education component of the HepConnect Initiative. The overarching goal of the project is to advance hepatitis C prevention for people who inject drugs by expanding harm reduction services and education through grant-making and technical assistance. Harm Reduction Coalition will be funding up to $6 million in grants over an initial 18-month period that support the expansion of harm reduction approaches to reduce the impact of hepatitis C and drug-related harms in the greater Appalachia region. Harm Reduction Coalition is seeking proposals that will build upon local expertise, uplift the voices and priorities of people who use drugs, and center racial justice.

Eligible applicants include organizations, coalitions, or groups with a 501(c)3 non-profit status or a fiscal sponsor with a 501(c)3 status that offer services in the five HepConnect initiative states (Indiana, Kentucky, Tennessee, West Virginia, and North Carolina); local and state health departments and other government entities are eligible to apply. Grant requests may range from $25,000 to $150,000. Applications are due July 31, 2019 by midnight ET.

For more information or to apply, visit here.


637020799465370000

About Kim Rodgers

Kim Rodgers is the Communications Manager at NACCHO.

More posts by Kim Rodgers

0 Comments

Related Posts

Cdc badge small
  • Tools & Resources

CDC Report: Temporary Reassignment of Personnel Requests...

CDC recently updated its flexibilities guidance for recipients and applicants...

Jul 09, 2020 | Kim Rodgers

CDC Report: Temporary Reassignment of Personnel Requests...

Jennifer kertanis headshot 24152456360
  • Opportunity

Top Moments From Day Two at NACCHO 360

Welcome to the final day of NACCHO 360! Yesterday NACCHO Chief Executive...

Jul 09, 2020 | Taylarr Lopez

Top Moments From Day Two at NACCHO 360

COVID VC Screenshot
  • COVID-19
  • Tools & Resources
  • Emergency Response
  • Infectious Disease

NACCHO’s COVID-19 Virtual Community Now Available to All...

NACCHO has opened our COVID-19 Virtual Community to all local health department...

Jul 08, 2020 | Kim Rodgers

NACCHO’s COVID-19 Virtual Community Now Available to All...

Sync2020 logos horizontal 1024x304
  • HIV, STI, & Viral Hepatitis

Scholarships Available: SYNChronicity 2020 Conference –...

SYNC 2020, the National Conference for HIV, HCV, STI and LGBTQ Health, is...

Jul 08, 2020 | Julia Zigman

Scholarships Available: SYNChronicity 2020 Conference –...

  • COVID-19
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

Kaiser Family Foundation: Reduction in Sexual and...

The Kaiser Family Foundation released a new issue brief, Potential Impacts of...

Jul 08, 2020 | Julia Zigman

Kaiser Family Foundation: Reduction in Sexual and...

2000px US CDC logo
  • HIV, STI, & Viral Hepatitis

New Recommendations for Hepatitis Vaccination

CDC has released new recommendations for hepatitis A virus (HAV) vaccination,...

Jul 08, 2020 | Julia Zigman

New Recommendations for Hepatitis Vaccination

TAG Logo
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

Treatment Action Group 2020 Pipeline Report Now Available

Treatment Action Group (TAG) recently published their 2020 Pipeline Report, an...

Jul 08, 2020 | Julia Zigman

Treatment Action Group 2020 Pipeline Report Now Available

Pr EP injectable
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

New Study: Injectable PrEP is Safe and Highly Effective

New data further shows an injectable antiretroviral for HIV pre-exposure...

Jul 08, 2020 | Julia Zigman

New Study: Injectable PrEP is Safe and Highly Effective

MMWR
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

HIV Testing Trends at Visits to Physician Offices,...

A recent report from CDC shows low rates of HIV testing in physician offices,...

Jul 08, 2020 | Julia Zigman

HIV Testing Trends at Visits to Physician Offices,...

Back to Top